🇺🇸 FDA
Patent

US 10800782

Inhibitors of cellular metabolic processes

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10800782 (Inhibitors of cellular metabolic processes) held by Agios Pharmaceuticals, Inc. expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00